Difference between revisions of "Gilead Sciences"
(basic overview) |
m (typo) |
||
| Line 12: | Line 12: | ||
|members=Daniel O’Day,Andrew Dickinson,William Lee,Jyoti Mehra,Johanna Mercia,Merdad Parsey,Brett A. Pletcher,Christi Shaw,Taiyin Yang, Donald Rumsfeld, George P. Shultz | |members=Daniel O’Day,Andrew Dickinson,William Lee,Jyoti Mehra,Johanna Mercia,Merdad Parsey,Brett A. Pletcher,Christi Shaw,Taiyin Yang, Donald Rumsfeld, George P. Shultz | ||
}} | }} | ||
| − | '''Gilead Sciences, Inc.''' is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including the | + | '''Gilead Sciences, Inc.''' is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including the heavily promoted [[Tamiflu]] and [[Remdesivir]]. Deep State actor [[Donald Rumsfeld]] have been Chairman, and [[George P. Schultz]] have been on the board. |
===Foundation=== | ===Foundation=== | ||
In June 1987, Gilead Sciences was originally founded under the name '''Oligogen''' by [[Michael L. Riordan]], a medical doctor. Three scientific advisers worked with Riordan to create the company: [[Peter Dervan]] of Caltech, [[Doug Melton]] of Harvard, and [[Harold M. Weintraub]] of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from the company's founding until 1996. | In June 1987, Gilead Sciences was originally founded under the name '''Oligogen''' by [[Michael L. Riordan]], a medical doctor. Three scientific advisers worked with Riordan to create the company: [[Peter Dervan]] of Caltech, [[Doug Melton]] of Harvard, and [[Harold M. Weintraub]] of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from the company's founding until 1996. | ||
Revision as of 10:24, 2 May 2020
 Gilead Sciences  (Big pharma)     | |
|---|---|
 | |
| Formation | 1987 |
| Founder | Michael L. Riordan |
| Headquarters | Foster City, California |
| Staff | 11,800 |
| Interest of | McLarty Associates |
| Subpage | •Gilead Sciences/Chair |
| Membership | • Daniel O’Day • Andrew Dickinson • William Lee • Jyoti Mehra • Johanna Mercia • Merdad Parsey • Brett A. Pletcher • Christi Shaw • Taiyin Yang •  Donald Rumsfeld• George P. Shultz |
| a pharma company with deep state connections | |
Gilead Sciences, Inc. is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including the heavily promoted Tamiflu and Remdesivir. Deep State actor Donald Rumsfeld have been Chairman, and George P. Schultz have been on the board.
Foundation
In June 1987, Gilead Sciences was originally founded under the name Oligogen by Michael L. Riordan, a medical doctor. Three scientific advisers worked with Riordan to create the company: Peter Dervan of Caltech, Doug Melton of Harvard, and Harold M. Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from the company's founding until 1996.
The company's primary therapeutic focus was in antiviral medicines. Since their founding in 1987, Gilead has routinely sought out partners for their drug products rather than trying to market them alone. Simultaneously they have attempted to grow by frequently acquiring their competitors.
Riordan recruited Donald Rumsfeld to join the board of directors in 1988, followed by Benno C. Schmidt Sr,Gordon Moore, and George P. Shultz.
In January 1997, Donald Rumsfeld was appointed Chairman, but left the board in January 2001 when he was appointed United States Secretary of Defense during George W. Bush's first term as President.
In 1999, Roche announced FDA approval of Tamiflu (oseltamivir) for the treatment of influenza. Tamiflu was originally discovered by Gilead and licensed to Roche for late-phase development and marketing.
In 2002 Gilead changed its corporate strategy to focus exclusively on antivirals.
Federal disclosure forms indicate that Rumsfeld as Secretary of Defense owned between USD$5 million and USD$25 million in Gilead stock. The rise in Gilead's share prices from USD$35 to USD$57 per share added between USD$2.5 million to USD$15.5 million to Rumsfeld's net worth[1], especially from government purchases of Tamiflu. In November 2005, George W. Bush urged Congress to pass $7.1 billion in emergency funding to prepare for the possible H5N1(bird flu) pandemic, of which one billion is solely dedicated to the purchase, and distribution of Tamiflu.
During the 2020 Covid-19 pandemic, their drug Remdesivir was heavily pushed[2] for people who are hospitalised with severe Covid-19, a procedure similar to the 2009 pushing of Tamiflu as a wonder medicine (governments in the end had to destroy massive and expensive surplus stock of an ineffective medicine).
The trial of Remdesivir was manipulated by Gilead: “Death and other negative outcomes were moved to secondary measure status: They would still be tracked, but they would no longer be the key measure of remdesivir’s performance. The switch — which specialists said is unusual in major clinical trials but not unheard of — was publicly disclosed on the government’s clinicaltrials.gov website on April 16 but did not receive much attention at the time.”[3]
Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
Known members
3 of the 12 of the members already have pages here:
| Member | Description |
|---|---|
| Étienne Davignon | Belgian deep politician, EU commissioner, Bilderberg chairman, Egmont Institute president |
| Donald Rumsfeld | Senior member of the cabal, former US Defense Secretary, got aspartame approved |
| George Shultz | US Cold warrior who attended the 1984 Washington Conference on International Terrorism |
